title: Immediate type 1 hypersensitivity to apomorphine: a case report.
authors: UGC Neumología-Alergia, Hospital Universitario Puerta del Mar, Cádiz, Spain. drgutierrez@comcadiz.com
authors: D
authors: D
authors: Gutiérrez
authors: A
authors: A
authors: Foncubierta
authors: R
authors: R
authors: Espinosa
authors: S
authors: S
authors: Astorga
authors: A
authors: A
authors: Leon
authors: S
authors: S
authors: Fernández
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001058:Apomorphine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004311:Double-Blind Method; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000139:chemically induced*; D007073:Immunoglobulin E / Q000276:immunology; D007279:Injections, Subcutaneous; D007428:Intradermal Tests; D008297:Male; D008875:Middle Aged; D010328:Patch Tests; D016037:Single-Blind Method; D012882:Skin Tests; D013447:Sulfites
chemical_list: D000978:Antiparkinson Agents; D013447:Sulfites; D007073:Immunoglobulin E; C005200:sodium metabisulfite; D001058:Apomorphine